Lung cancer (LC) incidence represents 11.5% of all new cancers, resulting in 1.72 million deaths worldwide in 2015. With the aim to investigate the capability of the electronic nose (e-nose) technology for detecting and differentiating complex...
Background: Evidence is increasing that microRNAs (miR) are particularly important in lung homeostasis and development and have been shown to be involved in many pulmonary diseases such as asthma, chronic obstructive pulmonary disease, sarcoidosis, lung cancer (LC) and other smoking-related diseases. Objective: The objective of this study was to investigate the expression of miR-155 and miR-486-5p in tissues from LC patients and healthy endobronchial mucosa as prognostic biomarkers for diagnosing LC. Methods: Bronchoscopic and thoracoscopic tissue biopsies were taken from 50 LC patients and other 50 control subjects without lung mass, who were planned for a clinical bronchoscopy. The expression of miR-155 and miR-486-5p in both tumor tissue and healthy mucosa were detected by quantitative real-time polymerase chain reaction. Results: Histopathology showed that 72% of LC patients were in advanced stages III and IV, with non-small cell lung carcinoma and adenocarcinoma being the most common diagnosis. miR-155 was significantly overexpressed while, miR-486-5p was underexpressed, in LC patients as compared to controls. Area under receiver operating characteristic curves of miR-155 (<-0.9) and miR-486 (>-0.62) have sensitivity of 92 and 96% and specificity of 80 and 84%, respectively, in discriminating LC patients from controls with benign solitary pulmonary nodules. Conclusion: miR-155 was highly overexpressed, yet didn’t correlate with stages, while miR-486-5p was extremely underexpressed and significantly correlated with stages of LC. Thus, their detection represents an excellent diagnostic/prognostic tool to support more established techniques linked to LC spread locally and systemically.
1 January 2014 in International Journal of Chemical and Applied Biological Sciences
Most gamma-ray scintillation detectors currently in use are made from inorganic materials that have a relatively high electron density. Quite often they are used to build multidetector systems that provide high scintillation light output. The performance of a gamma radiation detector (its detection efficiency) depends on the shape and size of the crystal, as well as on the source-to-detector geometry used. The NaI(Tl) gamma detector exhibits moderate energy resolution but relatively high gamma-ray detection efficiency and fast time response. In this work, the efficiency and resolution of a scintillation hexagonal detector are studied to optimize its response function. This type and size of scintillator were selected to construct a budget-friendly, reconfigurable, easy-to-maintain multidetector system for registering gamma-rays following fission, capture, and inelastic neutron scattering reactions, with reasonably good energy and time resolutions The research results made it possible to establish a geometric solid angle that increases the efficiency of recording gamma-ray radiation of the hexagonal NaI(Tl) scintillation probe under study.
22 April 2022 in Biomedical Physics & Engineering Express
A numerical analysis of specific absorption rate (SAR) and temperature distributions in a realistic human head model is presented in this study. The key challenge is to rise cancer temperature to an optimal temperature without heating nearby healthy tissues. The model’s uniqueness is that it captures the effect of nanoparticles on both brain cancer diagnosis and treatment. A realistic human head model with a cancerous brain segmented from 2D magnetic resonance imaging (MRI) gained from an actual patient using 3D Slicer, modeled, and simulated using CST-Microwave Studio, and illuminated by Archimedes spiral antenna. At frequencies of 2450 MHz and 915 MHz, the model simulated the absence and presence of various nanoparticles. The obtained results suggest that when using nanoparticles, it is possible to achieve sufficient energy deposition and temperature rise to therapeutic values (greater than 42 °C) in brain cancers using the proposed noninvasive hyperthermia system at 915 MHz frequency, especially for gold nanoparticles, without harming surrounding healthy tissue. Our research might pave the way for a clinical applicator prototype that can heat brain cancer.